<DOC>
	<DOCNO>NCT01806428</DOCNO>
	<brief_summary>Objective : test hypothesis recombinant activate protein C ( aPC ) therapy improve microcirculation severe septic patient . Design : Prospective , open study . Setting : University 12-beds intensive care unit . Patients : Septic patient least two sepsis-induced organ failure occur within 48 hour onset sepsis include one year period . Interventions : Patients contraindication aPC administration receive aPC dose 24 mcg/kg/h 96 hour . Patients contraindication aPC infusion consider control .</brief_summary>
	<brief_title>Activated Protein C Microcirculation</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<criteria>Septic patient least two sepsisinduced organ failure occur within 48 hour onset sepsis hematologic advance malignancy liver cirrhosis severely impaired consciousness ( Glasgow Coma Scale score &lt; 7 15 ) therapeutic limitation ( donotresuscitate order )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>